Clinical Trial

Celly Nutrition Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month – Created by a World-Class Pharmaceutical Research & Development Team

Vancouver, British Columbia--(Newsfile Corp. - August 9, 2024) - Celly Nutrition Corp. ("Celly Nu" or the "Company"), which is backed…

1 year ago

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

- Conference Call/Webcast Scheduled for Today at 4:30 PM ET - STONY BROOK, NY / ACCESSWIRE / August 8, 2024…

1 year ago

Avinger Reports Second Quarter 2024 Results

Implements Lower Operating Cost Profile, Readying OCT-Guided Coronary Device for IDE Submission REDWOOD CITY, CA / ACCESSWIRE / August 8,…

1 year ago

Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update

SEATTLE, WA / ACCESSWIRE / August 8, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing…

1 year ago

Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance

Application was Submitted on July 19, 2024, Passed the FDA Administrative Review, and is Now Under Substantive ReviewFDA Decision is…

1 year ago

Xtant Medical Announces $5.0 Million Private Placement

BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company…

1 year ago

Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%

BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology…

1 year ago

NanoViricides Provides an Update on Its Clinical Program and Strategy – NV-387 Could be As Revolutionary as Antibiotics

SHELTON, CT / ACCESSWIRE / August 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…

1 year ago

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

The potential addressable market opportunity for ONP-002 includes an estimated 69 million concussions globallySARASOTA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE)…

1 year ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results

Quoin Broadens Product Portfolio through Research Agreement with University College Cork, Ireland Company Expands On-going Clinical Trials in Netherton Syndrome…

1 year ago